文献速递呼吸危重症与机械通气

自主呼吸试验方法与成人重症患者再插管风险的网状Meta分析

Association Between Spontaneous Breathing Trial Methods and Reintubation in Adult Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Chest · 2024-07-02

该系统评价与贝叶斯网状Meta分析纳入22项随机对照试验共6196例成人重症患者,比较不同自主呼吸试验(SBT)方法与再插管风险的关系。与T管相比,仅高通量氧(HFO)SBT显著降低再插管风险(RR 0.23,95%CI 0.09-0.51,中等质量证据),HFO成为最佳干预的概率最高(81.86%,SUCRA 96.42)。

要点

  • 与T管相比,HFO SBT显著降低再插管风险(RR 0.23,95%CI 0.09-0.51)。
  • HFO成为最佳SBT干预的概率最高(81.86%,SUCRA 96.42)。
  • HFO SBT研究数量少且存在临床异质性,结果需谨慎解读。

核心结论

  • HFO SBT与其他SBT方法相比与更低的再插管风险相关。
  • 因研究HFO SBT的试验数量少且可能存在与共同干预相关的临床异质性,结果应谨慎解读。

研究设计与样本

  • 系统评价与贝叶斯网状Meta分析,纳入22项随机对照试验共6196例成人重症患者。
  • 检索PubMed、MEDLINE、CINAHL和Cochrane Central Register of Controlled Trials数据库,从建库至2024年1月26日。
  • 网状分析包括9个节点和13个直接两两比较。
  • 采用SUCRA确定干预成为最佳的可能性,并用频率学Meta分析进行两两比较。
  • 证据确定性按GRADE方法评估。

主要发现

  • 约71%的患者被分配至T管和無正压支持的通气模式,分别为2135例和2101例。
  • 与T管相比,唯一显著降低再插管风险的干预是高通量氧(HFO)(RR 0.23,95%CI 0.09-0.51,中等质量证据)。
  • HFO成为降低再插管风险最佳干预的概率最高(81.86%;SUCRA 96.42),其次是CPAP(11.8%;SUCRA 76.75)。

临床怎么用

  • 在成人重症患者拔管前SBT中,可考虑使用HFO SBT以降低再插管风险,但需结合研究局限性谨慎决策。

局限性

  • 研究HFO SBT的试验数量少。
  • 可能存在与共同干预相关的临床异质性。
  • 需在更大队列和特定亚组中进一步试验确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reintubation is associated with higher risk of mortality. There is no clear evidence on the best spontaneous breathing trial (SBT) method to reduce the risk of reintubation. RESEARCH QUESTION: Are different methods of conducting SBTs in critically ill patients associated with different risk of reintubation compared with T-tube? STUDY DESIGN AND METHODS: We conducted a systematic review and Bayesian network meta-analysis of randomized controlled trials investigating the effects of different SBT methods on reintubation. We surveyed PubMed, MEDLINE, CINAHL, and Cochrane Central Register of Controlled Trials databases from inception to January 26, 2024. The surface under the cumulative ranking curve (SUCRA) was used to determine the likelihood that an intervention was ranked as the best. Pairwise comparisons were also investigated by frequentist meta-analysis. Certainty of the evidence was assessed according to the Grading of Recommendations, Assessment, Development, and Evaluations approach. RESULTS: A total of 22 randomized controlled trials were included, for a total of 6,196 patients. The network included nine nodes, with 13 direct pairwise comparisons. About 71% of the patients were allocated to T-tube and pressure support ventilation without positive end-expiratory pressure, with 2,135 and 2,101 patients, respectively. The only intervention with a significantly lower risk of reintubation compared with T-tube was high-flow oxygen (HFO) (risk ratio, 0.23; 95% credibility interval, 0.09-0.51; moderate quality evidence). HFO was associated with the highest probability of being the best intervention for reducing the risk of reintubation (81.86%; SUCRA, 96.42), followed by CPAP (11.8%; SUCRA, 76.75). INTERPRETATION: In this study, HFO SBT was associated with a lower risk of reintubation compared with other SBT methods. The results of our analysis should be considered with caution due to the low number of studies that investigated HFO SBTs and potential clinical heterogeneity related to cointerventions. Further trials should be performed to confirm the results on larger cohorts of patients and to assess specific subgroups. TRIAL REGISTRATION: PROSPERO; No.: CRD42023449264; URL: https://www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ippolito M, Sardo S, Tripodi VF, et al. Association Between Spontaneous Breathing Trial Methods and Reintubation in Adult Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Chest. 2024. PMID: 38964674. doi:10.1016/j.chest.2024.06.3773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。